These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2945353)

  • 21. Human low-molecular-weight urinary urokinase. Partial characterization and preliminary sequence data of the two polypeptide chains.
    Schaller J; Nick H; Rickli EE; Gillessen D; Lergier W; Studer RO
    Eur J Biochem; 1982 Jul; 125(2):251-7. PubMed ID: 6749491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase in rheumatoid arthritis: causal or coincidental?
    Busso N; So A
    Ann Rheum Dis; 1997 Dec; 56(12):705-6. PubMed ID: 9496148
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification of urokinase-converting protease from human plasma.
    Hayashi S; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1120-6. PubMed ID: 3904292
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative studies on two active enzyme forms of human urinary urokinase. I. Purification by serial column chromatography and homogeneity analyses of molecular weight and isoelectric point.
    Miwa N; Takayanagi H; Suzuki A
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):463-71. PubMed ID: 7023709
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)].
    Wakayama Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved sensitivity of chromogenic substrate assays for urokinase and plasmin.
    Friedman RB; Kwaan HC; Szczecinski M
    Thromb Res; 1978 Jan; 12(1):37-46. PubMed ID: 148121
    [No Abstract]   [Full Text] [Related]  

  • 27. Assay methodology for urokinase: its use in assessing the composition of mixtures of high- and low-molecular weight urokinase.
    Philo RD; Gaffney PJ
    Thromb Res; 1981 Jan 1-15; 21(1-2):81-8. PubMed ID: 7015558
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material.
    Barlow GH; Marder VJ
    Thromb Res; 1980 May 1-15; 18(3-4):431-7. PubMed ID: 6998041
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinolysis potentiating activity following endothelial cells-platelet interaction.
    Flores-Delgado G; Hornebeck W; Legrand Y; Menashi S
    Thromb Res; 1994 Nov; 76(3):245-52. PubMed ID: 7863475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiolabeled streptokinase and urokinase and their comparative biodistribution.
    Som P; Rhodes BA; Bell WR
    Thromb Res; 1975 Mar; 6(3):247-53. PubMed ID: 1114491
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on human urinary enzymes and inhibitors. Concentration method and characterization.
    Sumi H; Toki N; Takada Y; Takada A
    J Biochem; 1978 Jan; 83(1):141-7. PubMed ID: 146706
    [No Abstract]   [Full Text] [Related]  

  • 32. Time-related release of various molecular forms of urokinase in tissue culture.
    Astedt B; Barlow G; Holmberg L
    Thromb Res; 1977 Aug; 11(2):149-53. PubMed ID: 905967
    [No Abstract]   [Full Text] [Related]  

  • 33. Isoelectric points of two molecular forms of human urinary urokinase determined by density-gradient isoelectric focusing and isotachoelectrophoresis.
    Miwa N; Sawada T; Suzuki A
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1513-6. PubMed ID: 7049421
    [No Abstract]   [Full Text] [Related]  

  • 34. Reagents for reversible coupling of proteins to the active centres of trypsin-like serine proteinases.
    Kalindjian SB; Smith RA
    Biochem J; 1987 Dec; 248(2):409-13. PubMed ID: 2963619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hydrolysis of alpha-CBZ-L-lysine-p-nitrophenyl ester by two forms of human urokinase.
    Ascenzi P; Bertollini A; Verzili D; Brunori M; Antonini E
    Anal Biochem; 1980 Apr; 103(2):235-9. PubMed ID: 6770709
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of calcium and magnesium ions on urinary urokinase and sialidase activity.
    van Aswegen CH; Dirksen van Sckalckwyk JC; du Toit PJ; Verster L; Franz RC; du Plessis DJ
    Urol Res; 1992; 20(1):41-4. PubMed ID: 1531276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A more serine way to die: defining the characteristics of serine protease-mediated cell death cascades.
    O'Connell AR; Stenson-Cox C
    Biochim Biophys Acta; 2007 Oct; 1773(10):1491-9. PubMed ID: 17888529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosyl residues of two molecular forms of human urinary urokinase: their ionization mode characterized by spectrophotometric and CD titrations and reactivity with cyanuric fluoride in relation to enzymic activity.
    Miwa N; Sawada T; Suzuki A
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1136-43. PubMed ID: 6758771
    [No Abstract]   [Full Text] [Related]  

  • 39. Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin.
    Liotta LA; Goldfarb RH; Terranova VP
    Thromb Res; 1981 Mar; 21(6):663-73. PubMed ID: 6455777
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of the amidolytic activity of urokinase by human plasma.
    Gallimore MJ
    Thromb Res; 1980 Jan 1-15; 17(1-2):289-91. PubMed ID: 6990549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.